镰状细胞贫血中弥漫性心肌纤维化与舒张功能障碍的关联
该研究利用心脏磁共振测量细胞外容积分数(ECV),在25例镰状细胞贫血(SCA)患者中定量弥漫性心肌纤维化,并评估其与舒张功能障碍的关联。结果显示所有患者ECV较对照组显著升高(0.44±0.08 vs 0.26±0.02,P<.0001),且ECV最高者(≥0.40)更易出现舒张功能障碍。结论认为弥漫性心肌纤维化是SCA常见且既往被低估的特征,与舒张功能障碍、贫血和高NT-proBNP相关。
要点
- SCA患者ECV较对照组显著升高(0.44±0.08 vs 0.26±0.02,P<.0001),提示弥漫性心肌纤维化。
- 71%患者存在舒张功能异常,29%符合舒张功能障碍定义。
- 舒张功能障碍者ECV更高(0.49±0.07 vs 0.37±0.04,P=.01),血红蛋白更低(8.4±0.3 vs 10.9±1.4 g/dL,P=.004)。
核心结论
- 由ECV测定的弥漫性心肌纤维化是SCA常见且既往被低估的特征,与舒张功能障碍、贫血和高NT-proBNP相关。
- 弥漫性心肌纤维化似乎是SCA舒张功能障碍的一种新机制。
研究设计与样本
- 研究纳入25例SCA患者(平均年龄23±13岁),采用心脏磁共振测量细胞外容积分数(ECV)定量弥漫性心肌纤维化,并以超声心动图评估舒张功能。
- ECV由血和心肌的钆剂注射前后T1测量值计算。
主要发现
- 所有参与者ECV较对照组显著升高(0.44±0.08 vs 0.26±0.02,P<.0001),提示弥漫性心肌纤维化。
- 17例(71%)存在舒张功能异常,7例(29%)符合舒张功能障碍定义。
- 舒张功能障碍者较舒张功能正常者ECV更高(0.49±0.07 vs 0.37±0.04,P=.01)、NT-proBNP更高(191±261 vs 33±33 pg/mL,P=.04)、血红蛋白更低(8.4±0.3 vs 10.9±1.4 g/dL,P=.004)。
- ECV最高值组(≥0.40)较ECV<0.4组更易出现舒张功能障碍(P=.003),左房容积指数更高(57±11 vs 46±12 mL/m2,P=.04)。
- ECV与血红蛋白相关(r=-0.46,P=.03),与NT-proBNP相关(r=0.62,P=.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sickle cell anemia (SCA)-related cardiomyopathy is characterized by diastolic dysfunction and hyperdynamic features. Diastolic dysfunction portends early mortality in SCA. Diastolic dysfunction is associated with microscopic myocardial fibrosis in SCA mice, but the cause of diastolic dysfunction in humans with SCA is unknown. We used cardiac magnetic resonance measurements of extracellular volume fraction (ECV) to discover and quantify diffuse myocardial fibrosis in 25 individuals with SCA (mean age, 23 ± 13 years) and determine the association between diffuse myocardial fibrosis and diastolic dysfunction. ECV was calculated from pre- and post-gadolinium T1 measurements of blood and myocardium, and diastolic function was assessed by echocardiography. ECV was markedly increased in all participants compared with controls (0.44 ± 0.08 vs 0.26 ± 0.02, P < .0001), indicating the presence of diffuse myocardial fibrosis. Seventeen patients (71%) had diastolic abnormalities, and 7 patients (29%) met the definition of diastolic dysfunction. Participants with diastolic dysfunction had higher ECV (0.49 ± 0.07 vs 0.37 ± 0.04, P = .01) and N-terminal pro-brain natriuretic peptide (NT-proBNP; 191 ± 261 vs 33 ± 33 pg/mL, P = .04) but lower hemoglobin (8.4 ± 0.3 vs 10.9 ± 1.4 g/dL, P = .004) compared with participants with normal diastolic function. Participants with the highest ECV values (≥0.40) were more likely to have diastolic dysfunction (P = .003) and increased left atrial volume (57 ± 11 vs 46 ± 12 mL/m2, P = .04) compared with those with ECV <0.4. ECV correlated with hemoglobin (r = -0.46, P = .03) and NT-proBNP (r = 0.62, P = .001). In conclusion, diffuse myocardial fibrosis, determined by ECV, is a common and previously underappreciated feature of SCA that is associated with diastolic dysfunction, anemia, and high NT-proBNP. Diffuse myocardial fibrosis is a novel mechanism that appears to underlie diastolic dysfunction in SCA.
引用
- Niss O, Fleck R, Makue F, et al. Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood. 2017. PMID: 28507082. doi:10.1182/blood-2017-02-767624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。